Search Results - "Pachynski RK"

IL-7: a potential next-generation adjuvant for immune cell therapies.

Authors: Hotchkiss RS DiPersio JF Yee C et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jan 02; Vol. 16, pp. 1736931. Date of Electronic Publication: 2026 Jan 02 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

AR and Beyond: ctDNA Maps Resistance Evolution in mCRPC.

Authors: Chauhan PS Pachynski RK Maher CA et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jun 15; Vol. 32 (12), pp. 2323-2325.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis.

Authors: Panikar SS Bansal D Crandall J et al.

Source: International journal of molecular sciences [Int J Mol Sci] 2026 Jun 05; Vol. 27 (11). Date of Electronic Publication: 2026 Jun 05.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

Authors: Sharma P Krainer M Saad F et al.

Source: Nature communications [Nat Commun] 2026 May 08. Date of Electronic Publication: 2026 May 08.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC).

Authors: Kyriakopoulos CE Pachynski RK Eickhoff JC et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Apr 24; Vol. 14 (4). Date of Electronic Publication: 2026 Apr 24.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.

Authors: Storrs E Mo CK Chou WH et al.

Source: Cancer discovery [Cancer Discov] 2026 Apr 17. Date of Electronic Publication: 2026 Apr 17.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer.

Authors: Matsubara N Petrylak D Ratta R et al.

Source: European urology oncology [Eur Urol Oncol] 2026 Apr; Vol. 9 (2), pp. 240-250. Date of Electronic Publication: 2025 May 13.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

PSMA-based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and the Future.

Authors: Ayzman A Pachynski RK Reimers MA

Source: Current treatment options in oncology [Curr Treat Options Oncol] 2025 May; Vol. 26 (5), pp. 375-384. Date of Electronic Publication: 2025 Apr 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

Therapeutic reprogramming of tumour-associated macrophages in pancreatic cancer using a cytotoxic CCR2-targeted nanotheranostic.

Authors: Somani VK Zhang X Chen TH et al.

Source: Molecular cancer [Mol Cancer] 2026 Feb 07; Vol. 25 (1). Date of Electronic Publication: 2026 Feb 07.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE; In Process

ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials.

Authors: Singhal K Schmidt E Kiwala S et al.

Source: ArXiv [ArXiv] 2025 Dec 09. Date of Electronic Publication: 2025 Dec 09.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101759493 Publication Model: Electronic Cited Medium: Internet ISSN: 2331-8422 (Electronic) Linking ISSN: 23318422 NLM ISO Abbreviation: ArXiv Subsets: PubMed not MEDLINE

Synergistic potential of sipuleucel-T in enhancing immunotherapy for metastatic castration-resistant prostate cancer.

Authors: Rawat K Punia V Mathews P et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Dec 05; Vol. 13 (12). Date of Electronic Publication: 2025 Dec 05.

Publication Type: Journal Article; Review

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

Authors: Einstein DJ Abel ML Aragon-Ching JB et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Dec; Vol. 43 (34), pp. 3672-3683. Date of Electronic Publication: 2025 Oct 23.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.

Authors: Luke JJ Gelmon K Siu LL et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jun 03; Vol. 31 (11), pp. 2134-2144.

Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).

Authors: Wise DR Pachynski RK Denmeade SR et al.

Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2025 Jun; Vol. 28 (2), pp. 363-369. Date of Electronic Publication: 2024 Feb 10.

Publication Type: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE

PACT: a pipeline for analysis of circulating tumor DNA.

Authors: Webster J Dang HX Chauhan PS et al.

Source: Bioinformatics (Oxford, England) [Bioinformatics] 2023 Aug 01; Vol. 39 (8).

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9808944 Publication Model: Print Cited Medium: Internet ISSN: 1367-4811 (Electronic) Linking ISSN: 13674803 NLM ISO Abbreviation: Bioinformatics Subsets: MEDLINE

Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.

Authors: Wu Y Terekhanova NV Caravan W et al.

Source: Nature communications [Nat Commun] 2023 May 17; Vol. 14 (1), pp. 2817. Date of Electronic Publication: 2023 May 17.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer.

Authors: Sweis RF Chatta GS Jain RK et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jan 17; Vol. 31 (2), pp. 299-307.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer.

Authors: Chauhan PS Alahi I Sinha S et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jan 06; Vol. 31 (1), pp. 151-163.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.

Authors: Wu Y Terekhanova NV Caravan W et al.

Source: Nature communications [Nat Commun] 2023 Mar 27; Vol. 14 (1), pp. 1681. Date of Electronic Publication: 2023 Mar 27.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry.

Authors: Lu P Oetjen KA Bender DE et al.

Source: Nature communications [Nat Commun] 2023 Mar 23; Vol. 14 (1), pp. 1601. Date of Electronic Publication: 2023 Mar 23.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE